Analyst Research
| Report Title | Price |
|---|---|
|
Trading Report for (MCK). A detailed report, including free correlated market analysis, and updates.
Provider: Stock Traders Daily
|
$58.00
|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: Stock Traders Daily
|
$495.00
|
|
Provider: Market Edge
|
$10.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
McKesson Corporation Declares Quarterly Dividend July 25, 2012
McKesson Corporation announced that it has declared a regular dividend of $.20 per share on Common Stock, payable on October 1, 2012, to stockholders of record on September 4, 2012.
Latest Developments for McKesson Corp
- McKesson Corp Issues FY 2014 EPS Guidance In Line With Analysts' Estimates
- McKesson Corp Completes Acquisition of Pss World Medical Inc
- McKesson Corp Lowers FY 2013 EPS Guidance
- McKesson Corp Announces Early Termination of Hart-Scott-Rodino Act Waiting Period for Acquisition of PSS World Medical Inc
Latest Key Developments in Pharmaceuticals
- Grifols SA’s Study Demonstrates Higher Dose Of PROLASTIN-C Increases Levels Of Alpha1-PI To Within Normal Range In Patients With AAT Deficiency-DJ
- Protalex Inc Announces Positive Interim Review of Phase 1b Trial Of PRTX-100 in Rheumatoid Arthritis By Independent Data Safety Monitoring Committee
- Pfizer Inc Announces Plan For Split-Off Of Zoetis Inc
- Salix Pharmaceuticals Ltd Announces Results For Budesonide Foam In Treatment Of Active Mild To Moderate Ulcerative Proctitis Or Ulcerative Proctosigmoiditis In Two Pivotal Phase 3 Studies
- Share this
- Link this
- Digg this
Follow Reuters